Could a single dose of esketamine calm severe depression during breast cancer surgery?
NCT ID NCT07374211
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a single low dose of esketamine, given during anesthesia for breast cancer surgery, can reduce severe depression and anxiety symptoms right after the operation. Researchers will enroll 242 women with severe depression who are scheduled for breast cancer removal. The goal is to see if this quick intervention improves mood and sleep without major side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- esketamine
- What this could lead to
- If it works, this could point toward a simple way to reduce severe depression and anxiety during breast cancer surgery recovery.
- What could go wrong
- This is an early-stage trial with only 242 participants, so results may not apply to everyone. Esketamine can cause side effects like dizziness or nausea.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Your voice may hold clues to depression – a new device listens in
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Could the sound of your voice reveal depression?
- Virtual reality may distract patients from pain and fear during anesthesia
- Can a personalized exercise program boost recovery in cancer survivors?